180 related articles for article (PubMed ID: 37787991)
1. Pathogenicity and Function Analysis of Two Novel SLC4A11 Variants in Patients With Congenital Hereditary Endothelial Dystrophy.
Zhen T; Li Y; Guo Q; Yao S; You Y; Lei B
Transl Vis Sci Technol; 2023 Oct; 12(10):1. PubMed ID: 37787991
[TBL] [Abstract][Full Text] [Related]
2. Fuchs Endothelial Corneal Dystrophy in a Heterozygous Carrier of Congenital Hereditary Endothelial Dystrophy Type 2 with a Novel Mutation in SLC4A11.
Kim JH; Ko JM; Tchah H
Ophthalmic Genet; 2015; 36(3):284-6. PubMed ID: 24502824
[TBL] [Abstract][Full Text] [Related]
3. SLC4A11 mutations causative of congenital hereditary endothelial dystrophy (CHED) progressing to Harboyan syndrome in consanguineous Pakistani families.
Firasat S; Dur-E-Shawar ; Khan WA; Sughra U; Nousheen ; Kaul H; Naz S; Noreen B; Gul R; Afshan K
Mol Biol Rep; 2021 Nov; 48(11):7467-7476. PubMed ID: 34637099
[TBL] [Abstract][Full Text] [Related]
4. Compound heterozygous mutations in the
Liu M; Xia JL; Yang H; Yu L
Ophthalmic Genet; 2022 Aug; 43(4):538-542. PubMed ID: 35291925
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing identified FAM149A as a plausible causative gene for congenital hereditary endothelial dystrophy, affecting Nrf2-Antioxidant signaling upon oxidative stress.
Zhang J; Dai Y; Wu D; Li Y; Xu J
Free Radic Biol Med; 2021 Sep; 173():117-124. PubMed ID: 34303830
[TBL] [Abstract][Full Text] [Related]
6. Observation of nine previously reported and 10 non-reported
Moazzeni H; Javadi MA; Asgari D; Khani M; Emami M; Moghadam A; Panahi-Bazaz MR; Hosseini Tehrani M; Karimian F; Hosseini B; Nekuie Moghadam T; Hassanpour H; Akbari MT; Elahi E
Br J Ophthalmol; 2020 Nov; 104(11):1621-1628. PubMed ID: 31420327
[TBL] [Abstract][Full Text] [Related]
7. [Identification of novel mutations of SLC4A11 gene in patients with congenital hereditary endothelial dystrophy].
Li Y; Zhang J; Xu JJ
Zhonghua Yan Ke Za Zhi; 2021 Feb; 57(2):133-138. PubMed ID: 33541055
[No Abstract] [Full Text] [Related]
8. Investigation of the functional impact of CHED- and FECD4-associated SLC4A11 mutations in human corneal endothelial cells.
Chung DD; Chen AC; Choo CH; Zhang W; Williams D; Griffis CG; Bonezzi P; Jatavallabhula K; Sampath AP; Aldave AJ
PLoS One; 2024; 19(1):e0296928. PubMed ID: 38252645
[TBL] [Abstract][Full Text] [Related]
9. Autosomal recessive CHED associated with novel compound heterozygous mutations in SLC4A11.
Aldave AJ; Yellore VS; Bourla N; Momi RS; Khan MA; Salem AK; Rayner SA; Glasgow BJ; Kurtz I
Cornea; 2007 Aug; 26(7):896-900. PubMed ID: 17667634
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation.
Alka K; Casey JR
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4258-4267. PubMed ID: 30140924
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the Corneal Endothelial Dystrophy-Associated Gene SLC4A11 Render the Cells More Vulnerable to Oxidative Insults.
Roy S; Praneetha DC; Vendra VP
Cornea; 2015 Jun; 34(6):668-74. PubMed ID: 25811729
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of Congenital Hereditary Endothelial Dystrophy and Fuchs Endothelial Corneal Dystrophy Associated With SLC4A11 Mutations in Affected Families.
Chaurasia S; Ramappa M; Annapurna M; Kannabiran C
Cornea; 2020 Mar; 39(3):354-357. PubMed ID: 31714402
[TBL] [Abstract][Full Text] [Related]
13. IPSC-Derived Corneal Endothelial-like Cells Act as an Appropriate Model System to Assess the Impact of SLC4A11 Variants on Pre-mRNA Splicing.
Brejchova K; Dudakova L; Skalicka P; Dobrovolny R; Masek P; Putzova M; Moosajee M; Tuft SJ; Davidson AE; Liskova P
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3084-3090. PubMed ID: 31323090
[TBL] [Abstract][Full Text] [Related]
14. Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy.
Salman M; Verma A; Chaurasia S; Prasad D; Kannabiran C; Singh V; Ramappa M
Orphanet J Rare Dis; 2022 Sep; 17(1):361. PubMed ID: 36115991
[TBL] [Abstract][Full Text] [Related]
15. SLC4A11 depletion impairs NRF2 mediated antioxidant signaling and increases reactive oxygen species in human corneal endothelial cells during oxidative stress.
Guha S; Chaurasia S; Ramachandran C; Roy S
Sci Rep; 2017 Jun; 7(1):4074. PubMed ID: 28642546
[TBL] [Abstract][Full Text] [Related]
16. Defective cell adhesion function of solute transporter, SLC4A11, in endothelial corneal dystrophies.
Malhotra D; Jung M; Fecher-Trost C; Lovatt M; Peh GSL; Noskov S; Mehta JS; Zimmermann R; Casey JR
Hum Mol Genet; 2020 Jan; 29(1):97-116. PubMed ID: 31691803
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional ion transport properties of human SLC4A11: comparison of the SLC4A11-B and SLC4A11-C variants.
Kao L; Azimov R; Shao XM; Frausto RF; Abuladze N; Newman D; Aldave AJ; Kurtz I
Am J Physiol Cell Physiol; 2016 Nov; 311(5):C820-C830. PubMed ID: 27581649
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of the SLC4A11 gene in autosomal recessive congenital hereditary endothelial dystrophy.
Sultana A; Garg P; Ramamurthy B; Vemuganti GK; Kannabiran C
Mol Vis; 2007 Jul; 13():1327-32. PubMed ID: 17679935
[TBL] [Abstract][Full Text] [Related]
19. Human Corneal Expression of SLC4A11, a Gene Mutated in Endothelial Corneal Dystrophies.
Malhotra D; Loganathan SK; Chiu AM; Lukowski CM; Casey JR
Sci Rep; 2019 Jul; 9(1):9681. PubMed ID: 31273259
[TBL] [Abstract][Full Text] [Related]
20. Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome.
Siddiqui S; Zenteno JC; Rice A; Chacón-Camacho O; Naylor SG; Rivera-de la Parra D; Spokes DM; James N; Toomes C; Inglehearn CF; Ali M
Cornea; 2014 Mar; 33(3):247-51. PubMed ID: 24351571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
